The S&P 500 soared more than 32% in 2013, and several big pharma companies also soared. Some, however -- namely Sanofi (SNY 0.04%), Novo Nordisk (NVO +1.84%), and Eli Lilly (LLY +0.40%) -- significantly trailed their peers. To find out why these stocks stumbled last year, and what they need to do to soar this year, click on the following slideshow.
